The therapeutic applications of cannabinoid agonists and antagonists

Bibliography

• COMPTON DR, RICE KC, DE COSTA BR, et al.: Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. (1993) 265:218–226.
   PubMed Web of Science ®Google Scholar
• KUSTER JE, STEVENSON JI, WARD SJ, et al.: Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther. (1993) 264:1352–1363.
   PubMed Web of Science ®Google Scholar
• MATSUDA LA, LOLAIT SJ, BROWNSTEIN MJ, et al.: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (1990) 346:561–564.
   PubMed Web of Science ®Google Scholar
• ••Molecular identification of the rat CBI receptor.
   Google Scholar
• MUNRO S, THOMAS KL, ABU-SHAAR M: Molecular characterization of a peripheral receptor for cannabinoids. Nature (1993) 365:61–65.
   PubMed Web of Science ®Google Scholar
• ••Molecular identification of the human CB2 receptor.
   Google Scholar
• GALLANT M, DUFRESNE C, GAREAU Y, et al.: New class of potent ligands for the human peripheral cannabinoid receptor. Bioorg. Med. Chem. Lett. (1996) 6:2263–2268.
   Web of Science ®Google Scholar
• •New selective agonists for the CB2 receptor.
   Google Scholar
• HUFFMAN JW, YU S, SHOWALTER V, et al.: Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. J. Med. Chem. (1996) 39:3875–3877.
   PubMed Web of Science ®Google Scholar
• •Description of a potent CB2 agonist.
   Google Scholar
• RINALDI-CARMONA M, BARTH F, HEAULME M, et al.: 5R141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. (1994) 350:240–244.
   PubMed Web of Science ®Google Scholar
• ••Description of a selective CBI receptor antagonist.
   Google Scholar
• BARTH F, RINALDI-CARMONA M, MILLAN J, et al.: SR144528, a potent and selective antagonist of the CB2 receptor. International Cannabinoid Research Society, 1997 Meeting. Stone Mountain, Georgia (July 1997).
   Google Scholar
• ••First description of a potent and selective CB2 antagonist.
   Google Scholar
• DEVANE WA, HANUS L, BREUER A, et al.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (1992) 258:1946–1949.
   PubMed Web of Science ®Google Scholar
• ••Description of the endogenous ligand, anandamide.
   Google Scholar
• MECHOULAM R, BEN-SHABAT S, HANUS L, et al.: Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. (1995) 50:83–90.
   PubMed Web of Science ®Google Scholar
• SUGIURA T, KONDO S, SUKAGAWA A: 2-arachidonylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. (1995) 215:89–97.
   PubMed Web of Science ®Google Scholar
• STELLA N, SCHWEITZER P, PIOMELLI D: A second endogenous cannabinoid that modulates long-term potentiation. Nature (1997) 388:773–778.
   PubMed Web of Science ®Google Scholar
• HERKENHAM M, LYNN AB, JOHNSON MR, et al.: Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. (1991) 11:563–583.
   PubMed Web of Science ®Google Scholar
• ••Description of CBI receptor localisation in rat brain.
   Google Scholar
• MAILLEUX P, VANDERHAEGHEN J-J: Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience (1992) 48:655–668.
   PubMed Web of Science ®Google Scholar
• WESTLAKE TM, HOWLETT AC, BONNER TI, et al.: Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience (1994) 63:637–652.
   PubMed Web of Science ®Google Scholar
• GLASS M, DRAGUNOW M, FAULL RLM: Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 77:299–318.
   PubMed Web of Science ®Google Scholar
• MATSUDA LA, BONNER TI, LOLAIT SJ: Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. (1993) 327:535–550.
   PubMed Web of Science ®Google Scholar
• •Description of CBI receptor mRNA localisation in rat brain.
   Google Scholar
• BUCKLEY NE, MEZEY E, BONNER T, et al.: Development of a CB2 knockout mouse. International Cannabinoid Research Society, 1997 Meeting. Stone Mountain, Georgia (July 1997).
   Google Scholar
• DEWEY WL: Cannabinoid pharmacology. Pharmacol. Rev. (1986) 38:151–178.
   PubMed Web of Science ®Google Scholar
• DEROCQ JM, SEGUI M, MARCHAND J, et al.: Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. (1995) 369:177–182.
   PubMed Web of Science ®Google Scholar
• •Evidence for immunostimulant properties of A9-THC.
   Google Scholar
• LYNN AB, HERKENHAM M: Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J. Pharmacol. Exp. Ther. (1994) 268:1612–1623.
   PubMed Web of Science ®Google Scholar
• •Description of CB2 receptor localisation.
   Google Scholar
• GALIEGUE S, MARY S, MARCHAND J, et al.: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. (1995) 232:54–61.
   PubMedGoogle Scholar
• •Description of CB2 receptor localisation.
   Google Scholar
• GAREAU Y, DUFRESNE C, GALLANT M, et al.: Structure activity relationships of the tetrahydrocannabinol analogues on human cannabinoid receptors. Bioorg. Med. Chem. Lett. (1996) 6:189–194.
   Web of Science ®Google Scholar
• SIM LJ, HAMPSON RE, DEAD WYLER SA, CHILDERS SR: Effects of chronic treatment with A9-tetrahydrocannabinol on cannabinoid-stimulated [355]-GTPyS autoradiography in rat brain. J. Neurosci. (1996) 16:8057–8066.
   PubMed Web of Science ®Google Scholar
• PETITET F, JEANTAUD B, REIBAUD et al.: Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of A9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci. Pharmacol. Lett. (In press).
   Google Scholar
• BOUABOULA M, PERRACHON S, MILLIGAN L, et al.: A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. J. Biol. Chem. (1997) 272:22330–22339.
   PubMed Web of Science ®Google Scholar
• •Evidence for inverse agonist activity of SR141716A.
   Google Scholar
• FAHEY K, CHANEY M, CULLINAN G, et al.: The synthesis and biological activity of a novel class of antagonists for the brain C131 cannabinoid receptor. Soc. Neurosci. Abstr. (1995) 21:1144
   Google Scholar
• CRAVATT BF, GIANG DK, MAYFIELD SP, et al.: Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature (1997) 384:83–87.
   Web of Science ®Google Scholar
• ••Molecular identification of an enzyme that hydrolyses anandamide.
   Google Scholar
• GIANG DK, CRAVATT BF: Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. USA (1997) 94:2238–2242.
   PubMed Web of Science ®Google Scholar
• DEUTSCH DG, LIN S, HILL WAG, et al.: Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem. Biophys. Res. Commun. (1997) 231:217–221.
   PubMed Web of Science ®Google Scholar
• BELTRAMO M, DI TOMASO E, PIOMELLI D: Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthaleny1)-2H-pyran-2-one. FEBS Lett. (1997) 403:263–267.
   PubMed Web of Science ®Google Scholar
• DEUTSCH DG, OMEIR R, ARREAZA G, et al.: Methyl arachidonyl fluorophosphate: a potent irreversible inhibitor of anandamide amidase. Biochem. Pharmacol. (1997) 53:255–260.
   PubMed Web of Science ®Google Scholar
• FOWLER C, STENSTROM A, TIGER G: Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide. Pharmacol. Toxicol. (1997) 80:103–107.
   PubMedGoogle Scholar
• BELTRAMO M, STELLA N, CALIGNANO A, et al.: Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science (1997) 277:1094–1097.
   PubMed Web of Science ®Google Scholar
• ••First description of an anandamide transporter.
   Google Scholar
• CALIGNANO A, LA RANNA G, BELTRAMO M, et al.: Potentiation of anandamide hypotension by the transport inhibitor AM404. Eur. J. Pharmacol. (1997) 337:R1–R2.
   PubMed Web of Science ®Google Scholar
• DEVANE WA, DYSARZ FA, JOHNSON MR, et al.: Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. (1988) 34:605–613.
   PubMed Web of Science ®Google Scholar
• GERARD CM, MOLLEREAU CM, VASSART G, PARMENTIER M: Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. (1991) 279:129–134.
   PubMed Web of Science ®Google Scholar
• ••Molecular identification of the human central cannabinoid receptor.
   Google Scholar
• HOWLETT AC, FLEMING RM: Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. (1984) 26:532–538.
   PubMed Web of Science ®Google Scholar
• COLLINS DR, PERTWEE RG, DAVIES SN: Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br. J. Pharmacol. (1995) 115:869–870.
   PubMed Web of Science ®Google Scholar
• MANSBACH RS, ROVETTI CC, WINSTON EN, LOWE JA, III: Effects of the cannabinoid C131 receptor anatgonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (1996) 124:315–322.
   PubMed Web of Science ®Google Scholar
• TERRANOVA JP, STORNE JJ, LAFON N, et al.: Improvement of memory in rodents by the selective C131 cannabinoid receptor antagonist, SR141716A. Psychopharmacology (1996) 126:165–172.
   PubMed Web of Science ®Google Scholar
• BRODKIN J, MOERSCHBAECHER JM: SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats. J. Pharmacol. Exp. Ther. (1997) 282:1526–1532.
   PubMed Web of Science ®Google Scholar
• CHEN J, PAREDES W, LI J, et al.: 49-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (1990) 102:156–162.
   PubMed Web of Science ®Google Scholar
• TANDA G, PONTIERI FE, DI CHIARA G: Cannabinoid and heroin activation ofmesolimbic dopamine transmission by a common pi opioid receptor mechanism. Science (1997) 276:2048–2050.
   PubMed Web of Science ®Google Scholar
• •This paper describes how cannabinoids and opiates share a common mechanism to stimulate a dopaminergic pathway.
   Google Scholar
• CHEN J, PAREDES W, LOWINSON JH, GARDNER EL: 49-Tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur. J. Pharmacol. (1990) 190:259–262.
   PubMed Web of Science ®Google Scholar
• GARDNER EL, LOWINSON JH: Marijuana's interaction with brain reward systems: update 1991. Pharmacol. Biochem. Behav. (1991) 40:571–580.
   PubMed Web of Science ®Google Scholar
• FRENCH ED, DILLON K, WU X: Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. NeuroReport (1997) 8:649–652.
   PubMed Web of Science ®Google Scholar
• •Electrophysiological evidence that cannabinoids stimulate dopaminergic neurones.
   Google Scholar
• COMPTON DR, ACETO MD, LOWE J, MARTIN BR: In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of 49-tetra-hydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther. (1996) 277:586–594.
   PubMed Web of Science ®Google Scholar
• GLASS M, BROTCHIE JM, MANEUF YP: Modulation of neurotransmission by cannabinoids in the basal ganglia. Eur. J. Neurosci. (1997) 9:199–203.
   PubMed Web of Science ®Google Scholar
• HIMMI T, DALLAPORTA M, PERRIN J, ORSINI J-C: Neuronal responses to 49-tetrahydrocannabinol in the solitary tract nucleus. Eur. J. Pharmacol. (1996) 312:273–279.
   PubMed Web of Science ®Google Scholar
• MATTES RD, ENGELMAN K, SHAW LM, ELSOHLY MA: Cannabinoids and appetite stimulation. Pharmacol. Biochem. Behav. (1994) 49:187–195.
   PubMed Web of Science ®Google Scholar
• ARNONE M, MARUANI J, CHAPERON F, et al.: Selective inhibition of sucrose and ethanol intake by 5R141716A, an antagonist of central cannabinoid (CBI.) receptors. Psychopharmacology (1997) 132:104–106.
   PubMed Web of Science ®Google Scholar
• •Describes the effect of a selective CBI antagonist on ingestive behaviour.
   Google Scholar
• SOFIA RD, KNOBLOCH LC: Comparative effects of various naturally occuring cannabinoids on food, sucrose and water consumption by rats. Pharmacol. Biochem. Behav. (1976) 4:591–599.
   PubMed Web of Science ®Google Scholar
• LAKE KD, COMPTON DR, VARGA K, et al.: Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J. Pharmacol. Exp. Ther. (1997) 281:1030–1037.
   PubMed Web of Science ®Google Scholar
• WAGNER JA, VARGA K, ELLIS EF, et al.: Activation of peripheral cannabinoid receptors in haemorrhagic shock. Nature (1997) 390:518–521.
   PubMed Web of Science ®Google Scholar
• SLIPETZ DM, O'NEILL GP, FAVREAU L, et al.: Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol. Pharmacol. (1995) 48:352–361.
   PubMed Web of Science ®Google Scholar
• FELDER CC, JOYCE KE, BRILEY EM, et al.: Comparison of the pharmacology and signaltransduction of the human cannabinoid CBI and CB2 receptors. Mol. Pharmacol. (1995) 48:443–450.
   PubMed Web of Science ®Google Scholar
• MORRIS K: The cannabis remedy - wonder worker or evil weed Lancet (1997) 350:1828.
   PubMed Web of Science ®Google Scholar
• NAINGGOLAN L: Marijuana - a missed market opportunity Scrip Magazine (December 1997):22–26.
   Google Scholar